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Abstract: Multimorbidity and socioeconomic position are independently associated with mortality.
We investigated the association of occupational position and several multimorbidity measures with
all-cause mortality. A cohort of people aged 35 to 75 years who participated in the Trøndelag Health
Study in 2006–2008 and had occupational data was linked to the Norwegian National Population
Registry for all-cause mortality from study entry until 1 February 2019. Logistic regression models
for each occupational group were used to analyze associations between the number of conditions
and 10-year risk of death. Cox regression models were used to examine associations between
combinations of multimorbidity, occupational position, and mortality. Analyses were conducted for
men and women. Included were 31,132 adults (16,950 women (54.4%)); occupational groups: high,
7501 (24.1%); low, 15,261 (49.0%)). Increased mortality was associated with lower occupational group,
more chronic conditions, and all multimorbidity measures. The joint impact of occupational group
and multimorbidity on mortality was greater in men than women. All multimorbidity measures
are strongly associated with mortality, with varying occupational gradients. Social differences in
multimorbidity are a public health challenge and necessitate consideration in health care. Men in
lower occupational groups seem to be a particularly vulnerable group.
Keywords: multimorbidity; frailty; socioeconomic status; mortality; occupations; public health;
health inequality; The HUNT Study
1. Introduction
The burdens of disease and death are greater for people in lower socioeconomic positions
worldwide [1]. Multimorbidity, the concurrence of multiple chronic conditions [2], is highly
prevalent [3,4], while health inequalities are most often studied in association with individual diseases.
Multimorbidity may co-occur with frailty [5,6], which is a dynamic, multidimensional symptom
complex of accumulated decline in homeostatic reserves that results in increased vulnerability [4].
Both concepts are proxy measures of biological aging [7].
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Numerous operational definitions and differences in methods and settings hamper the
comparability of research on multimorbidity [8–10] and frailty [6,11]. Still, in cross-sectional studies,
acknowledged common determinants associated with multimorbidity and frailty are socioeconomic
deprivation [8,12], female sex [8,13], and higher age [8,13]. In Norway, previous studies on complex
measures of multimorbidity, including frailty, reproduced increased prevalence in people in lower
occupational groups, women, and older adults [14,15]. While the prevalence of multimorbidity and
frailty rise with higher age, those younger than 65 years encompass a larger number of individuals
with multimorbidity and frailty [15–18].
A review of 26 cohort studies in populations older than 65 years established that,
despite heterogeneity, any multimorbidity increases mortality [19]. Only five studies adjusted for
sociodemographic variables which reduced the effect estimates of multimorbidity on mortality [19].
It was not possible to pool the existing data with regards to sex differences [19]. Multimorbidity
measured as three or more long-term conditions increases specificity in older age [9,20]. Furthermore,
requiring these multiple conditions to be present in separate body systems identifies multimorbidity
that is likely to require care from several specialists, which has been termed complex multimorbidity [20].
Such complex multimorbidity presented a moderate relationship with mortality, adjusted for
sociodemographic characteristics, in a study on individuals aged 60 to 69 years in Norway [21].
While various frailty measures identify distinct subgroups, all are associated with mortality [22].
Frailty consistently increased mortality risk when adjusted for multimorbidity and socioeconomic
position in a population cohort aged 37 to 73 years [18]. Joint multimorbidity and frailty increased the
mortality risk in older adults, while the separate measures did not [23]. Adjustment by socioeconomic
position did not modify this relationship [23].
The relation of socioeconomic position with health outcomes vary by measure because each act
through distinct mechanisms [24,25]. Modification of multimorbidity’s association with mortality has
been explored by education [26,27], occupation [27], and deprivation indices [28,29]. Occupation is
a comprehensive measure, reflecting income, material resources, and networks, as well as specific
outcomes of biopsychosocial exposure on the job [25].
There are few studies examining the joint outcome of socioeconomic position and multimorbidity
on mortality [26–29]. The studies vary in exploring one measure [27,28] or several measures [26,29]
of multimorbidity and 1 measure [26,28,29] or several measures [27] of socioeconomic position
throughout adulthood [26,28] or in restricted age groups [27,29] with a follow-up time ranging from
4 years [26] to 24 years [27]. Overall, they find multimorbidity is more common in those with social
deprivations [26,28,29], while the association with subsequent mortality varies in presence [28,29] or
absence [26,27] of sex differences and is reported as stable [29], reduced [26], and nonexistent [27]
across socioeconomic strata.
In summary, multimorbidity and frailty share determinants, and like socioeconomic position,
they are associated with mortality. There is a research gap in exploring the impact of multimorbidity,
and possible pooled effect of multimorbidity and frailty [7] on mortality in various social strata and
younger age groups [10].
Our aim was to explore how occupational position may modify the relationship between several
measures of multimorbidity, including multimorbidity with frailty, and mortality in the general
population. The study is conducted in a Nordic welfare state and results can be contrasted with similar
studies conducted in a different welfare regime type model [30]. We report absolute and relative
differences in all-cause mortality by occupational groups and sex and compare the prognostic value of
different multimorbidity measures. We hypothesize that socioeconomic position will interact with all
measures of multimorbidity and individuals in lower occupational groups will have worse prognoses.
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2. Materials & Methods
2.1. Study Population and Sample
The Trøndelag Health Study (HUNT) is an ongoing population-based health study that invites
all citizens of Trøndelag County, Norway, 20 years and older to participate. The current study used
baseline data from the HUNT Study 2006–2008 (HUNT3), which invited a total of 93,860 individuals
to participate. We report in accordance with Strengthening the Reporting of Observational Studies
in Epidemiology (STROBE) guidelines for cohort studies [31]. Details on cohort profiles and data
collection procedures have been published previously [32,33]. In short, participants were defined as
responders to the main questionnaire, which was sent with the invitation by mail. Overall, 50,807 of
93,860 individuals (54.1%) participated in HUNT3 [32].
To be eligible for analysis in this cohort study, participants had to complete all major parts of
HUNT3 (the main questionnaire, attend a screening station for interview, clinical measurements,
and blood samples and return by mail a second questionnaire specific to age group and sex). Finally,
classifiable occupational data, in addition to registry data (age, sex, and mortality status), were required.
Figure 1 presents a flowchart for the sample selection. Individuals younger than 35 years were excluded
upon expected low statistical power and to minimize the risk of misclassification by occupational
group. Participants 75 years or older were omitted to minimize the effect of older adults in good
health causing underestimation of occupational group differences in the association of multimorbidity
with mortality.
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2.2. Outcome Variable
All-Cause Mortality
The Norwegian National Population Registry administers all-cause mortality, from which the
HUNT Databank regularly obtains registry status describing individuals in its cohort as being alive,
having emigrated out of the country, or being dead. The registry data are linked on an individual level
and there is no loss to follow-up. The last update from the National Population Registry and end of
follow-up was 1 February 2019.
2.3. Independent Variables
Multimorbidity
We previously generated a set of 51 individual, chronic conditions from HUNT3 data [14,15]
and further allocated those to body systems [14] by use of 14 chapters in the International
Statistical Classification of Diseases 10th Revision (ICD-10) (supplementary data 1), hereafter called
organ-grouped conditions.
From this set and categorization of chronic conditions, we created five multimorbidity measures
of which two were continuous and three were categorical measures as follows:
(1) individual disease counts;
(2) organ-grouped disease counts;
(3) a threshold of three or more individual conditions;
(4) a threshold of three or more organ-grouped conditions called complex multimorbidity;
(5) co-occurrence of two or more individual conditions and frailty (measured as one of four
dimensions (poor self-rated health, mental illness, physical impairment or social impairment))
called multimorbidity with frailty.
Both the multimorbidity and frailty measure included anxiety and depression. In total, 23 of
11,861 individuals met the criteria of two-condition multimorbidity plus one dimension of frailty,
with the presence of anxiety and depression only.
Complex multimorbidity [20] and multimorbidity with frailty [34] are measures suggested
to detect individuals in higher need of coordinated care which was previously operationalized in
HUNT3 [14,15]. Organ-grouped disease counts were used in sensitivity analyses.
2.4. Sociodemographic Variables
Continuous age and categorical sex variables were provided by the HUNT Databank. Our proxy
variable for socioeconomic position was occupation, derived from the interview question “What is/was
the title of your main occupation?” Occupation is a comprehensive measure reflecting income,
material resources, and networks, as well as specific biopsychosocial exposures on the job [25].
Occupations were categorized according to the simplified, 3-class version of the European
Socio-economic Classification scheme (supplementary data 2) [35].
2.5. Statistical Analysis
To show the distribution of follow-up time and events, demographic factors, and baseline health
characteristics across occupational groups, cross-tabulations were conducted. Numbers of affected
individuals, percentages, and measures of central tendency and variability are presented.
Logistic, linear, and Cox regression models were used. First, logistic regression models were
fitted separately for each sex and occupational group to study associations between the number of
individual chronic conditions, entered as restricted cubic splines, and death in the following 10-year
period. These models were adjusted for continuous age. Results from each model were subsequently
combined in a joint graph showing mortality as estimated proportions (with 95% confidence intervals
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(CIs)) at age 60 years and presented for 0 to 12 individual chronic conditions. Joint graphs of the
complete range of individual chronic conditions, as well as a sensitivity analysis in which the same
method was used to study the association between the number of organ-grouped chronic conditions
and 10-year risk of death and accompanying descriptive tables of frequencies and number of events by
individual and organ-grouped conditions, are in supplementary data 3. The logistic regression model
to study the associations of organ-grouped chronic conditions necessitated the inclusion of age squared.
Second, to formally test if multimorbidity was modified by occupation, we specified linear regression
models to investigate statistical interactions between continuous multimorbidity and occupation on
an additive scale. We also fit models with statistical interactions between multimorbidity and sex.
The threshold significance level was p < 0.05.
Finally, we modeled time to death using sex-stratified Cox proportional hazard models with a
composite variable containing different combinations of multimorbidity (yes or no) and occupation
(low, middle, or high). We used age measured in years as the time scale to either date of emigration,
all-cause mortality, or end of follow-up (1 February 2019), whichever came first. We report hazard
ratios with 95% CIs in forest plots. The number of deaths, total frequency, and proportions are listed by
joint multimorbidity and occupational group measures, sex, and occupational groups in supplementary
data 4.
All statistical analyses were done in Stata IC (StataCorp. 2019. Stata Statistical Software: Release 16.
StataCorp LLC, College Station, TX, USA) and all visualizations were created with the user-written
Stata coefplot command [36]. Data analysis took place from January to June 2020.
2.6. Patient and Public Involvement
Participants, patients, and stakeholders took part in the preparation of HUNT3. The data collection
was completed from October 2006 to June 2008. At the time of designing this secondary analysis study,
no patient groups represented the universal topic multimorbidity, and therefore no patient or public
representatives were involved.
2.7. Ethics Statement
The Regional Committee for Medical and Health Research Ethics in Norway approved the current
study (project no. 2014/2265).
3. Results
Included in the analyses were 31,132 of 50,807 HUNT3 participants (61.3%) with complete data on
multimorbidity, work, and registry status (Figure 1), followed for a mean (standard deviation (SD)) of
11.1 (1.5) years (Table 1). Individuals were excluded because of withdrawn consent (n = 6), incomplete
participation (n = 9610), unspecified occupation (n = 25), or missing occupational data (n = 1571),
younger than 35 years (n = 4827) or 75 years or older (n = 3636). No individuals were excluded due to
missing registry data. Sociodemographic characteristics for individuals who were ineligible or had
missing data are presented in supplementary data 5.
Nearly half the sample (15,261 of 31,132 (49.0%)) were designated as part of the low occupational
groups, and a quarter (7501 of 31,132 (24.1%)) were in the high occupational group. The low occupational
group had higher proportions of all measures of multimorbidity and reported a higher number of
long-term conditions. A total of 2254 of 31,132 individuals (7.2%) died by the end of the study.
By occupational group, this included 373 of 7501 (5.0%) in the high occupational group and 1310 of
15,261 (8.6%) in the low occupational group. Among the groups of multimorbidity, 1795 of 19,409
individuals (9.2%) with three or more individual conditions died, as did 1642 of 16,546 individuals
(9.9%) with complex multimorbidity and 1312 of 11,861 individuals (11.1%) with multimorbidity and
frailty (supplementary data 4). Risk of death according to occupation and number of individual chronic
conditions are depicted for women and men in Figure 2.
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Table 1. Sociodemographic characteristics and health profile at baseline and follow-up time and events
in occupational strata, the HUNT Study 2006–2008 (HUNT3).
Characteristics and Outcomes
Occupational Group
High Middle Low Total
Cohort, baseline, No. (%) 7501 (100) 8370 (100) 15,261 (100) 31,132 (100)
Women No. (%) 3702 (49.4) 4427 (52.9) 8821 (57.8) 16,950 (54)
Men No. (%) 3799 (50.6) 3943 (47.1) 6440 (42.2) 14,182 (46)
Age, years, mean (SD) 53 (10.2) 55 (10.7) 56 (10.5) 55 (10.5)
Health status, baseline
Individual LTCs, median (IQR) 3 (1 to 5) 3 (2 to 5) 4 (2 to 6) 3 (2 to 5)
Organ-grouped LTCs, median (IQR) 2 (1 to 3) 3 (1 to 4) 3 (2 to 4) 3 (1 to 4)
≥3 individual LTCs, No. (%) 3919 (52.2) 5088 (60.8) 10,402 (68.2) 19,409 (62.3)
Complex multimorbidity, No. (%) a 3191 (42.5) 4298 (51.4) 9057 (59.3) 16,546 (53.1)
Multimorbidity with frailty, No. (%) b,c 2070 (27.6) 3081 (36.8) 6710 (44.0) 11,861 (38.1)
End of follow-up
Follow-up time, years, mean (SD) 11.1 (1.3) 11.1 (1.5) 11.0 (1.6) 11.1 (1.5)
Person-years, thousands (%) 83.5 (24.3) 93.0 (27.0) 167.6 (48.7) 344.2 (100)
Deaths, No. (%) 373 (5.0) 571 (6.8) 1310 (8.6) 2254 (7.2)
Deaths in women, No. (%) 118 (31.6) 210 (36.8) 608 (46.4) 936 (41.5)
Deaths in men, No. (%) 255 (68.4) 361 (63.2) 702 (53.6) 1318 (58.5)
Age at death, years, mean (SD) 71.2 (8.7) 72.9 (8.2) 71.9 (8.6) 72.0 (8.5)
Abbreviations: No., number; SD, standard deviation; IQR, interquartile range; LTC, long-term condition. a Three or
more organ-grouped LTCs. b Two or more individual LTCs and one dimension of frailty (poor health, mental illness,
physical or social impairment). c In total, 15 people had data missing on frailty.
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p = 0.41), whereas for men, the low occupational group had a steeper increase than the middle and high
occupational groups (additive statistical interaction p < 0.001). We also found evidence of a statistically
significant interaction in which the number of conditions was more strongly associated with mortality
for men compared with the same association in women (additive statistical interaction p = 0.03).
A sensitivity analysis with multimorbidity measured as organ-grouped chronic conditions found the
same statistical interactions and associations. In contrast to individual disease count, occupational
differences in the risk of death in women were detectable for the full range of organ-grouped conditions
(supplementary data 3, Figure S2).
Figure 3 shows hazard ratios (HRs) and 95% CI for mortality according to combinations of the
categorical multimorbidity measures and occupation levels for women and men.J. Clin. Med. 2020, 9, x FOR PEER REVIEW 7 of 13 
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Compared with the reference category (individuals in the high occupation group whose health
status was below the threshold of multimorbidity), the overall pattern suggests that the relative risk of
death increased gradually with decreasing occupation levels and the presence of multimorbidity for
both women and men. There was more than a two-fold risk of death in the low occupational group
with all measures of multimorbidity compared with the reference category for both women and men.
4. Discussion
4.1. Summary of Findings
In this populatio cohort study on joint outcomes of socioeconomic position and multimorbidity
on mortality, we found that all measures of multimorbidity and all-cause mortality were more
common in lower occupational groups. Mortality increased with the number of chronic conditions,
and occupational gradients were consistent. There was a tendency toward a stronger association
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between multimorbidity and mortality in men in lower occupational groups. Relative risk differences
increased with lower occupational groups and the presence of multimorbidity.
4.2. Possible Mechanisms and Explanations
Socioeconomic differences in mortality result from unequal distribution of power, income,
and resources [1]. Occupational position entails these general elements and particular outcomes of
biopsychosocial exposures in the workplace [25], where negative factors tend to concentrate in lower
occupational groups [1]. Multimorbidity may be associated with death through the lethality of each
condition, interplay between conditions (including frailty), and conditions and treatments (such as
polypharmacy and fragmented health care) [19]. The presence of frailty should initiate comprehensive,
integrated care in patients with 2 or more individual conditions [34]. In this study, the relative risks
were greatest with the presence of joint multimorbidity and frailty.
Because mortality increases with individual disease counts and any multimorbidity measure,
a decrease in absolute and relative socioeconomic differences can be expected [37]. In women,
absolute risk differences were diminished in the high occupational group, while the gradient between
middle and low occupational groups persisted. This may imply heterogeneity in the multimorbidity
measure, particularly in women. The occupational differences in mortality were greater by count of
organ-grouped chronic conditions (supplementary data 3), and this may reflect that grouping by body
system makes the measure more uniform and enables it to detect social gradients to a greater extent
than simple disease counts. It seems that a continuous measure of multimorbidity better captures the
impact of socioeconomic position on mortality.
4.3. Comparison with Existing Literature
In a review of 26 articles on the association between multimorbidity and mortality, all measures
of multimorbidity increased mortality [19]. Three recent population cohorts, including 240,000
individuals [26] to 1.1 million individuals [28] and one worker cohort of 6425 people [27], have studied
the joint outcome of socioeconomic position and multimorbidity on mortality. Two studies also explored
the association of socioeconomic position with the transition from healthy to multimorbid [27,28] and
frail [27]. Multimorbidity was measured as individual disease counts of 39 chronic conditions [26] or
43 chronic conditions [29] and as a threshold of 2 or more of 9 long-term conditions [27] and 30 long-term
conditions [28]. Proxies for socioeconomic position were education [26,27], occupation [27], and area
deprivation [28,29].
Similar to our findings, all [26–29] reported higher prevalence of multimorbidity in lower
socioeconomic groups and more deaths with increasing multimorbidity and lower social position.
With increasing disease count in a range of zero to more than four conditions, the impact of
socioeconomic position on mortality were considered to decrease [26] or be stable [29]. The effect of
increasing disease counts on mortality risk was larger among men [29], which corresponds to our
findings. On the other hand, our study suggests increased mortality with consistent occupational
gradients, with increasing disease counts for a greater range of individual conditions.
Socioeconomic position measured as occupation had the strongest association with onset of
multimorbidity, physical frailty, and mortality [27]. In the presence of multimorbidity and frailty
studied as separate measures, there were no social gradients in mortality [27]. In contrast, our study
suggested intact occupational gradients in the presence of all categorical measures of multimorbidity.
Finally, in women with multimorbidity, life expectancy was equal across social strata, while men
with multimorbidity had sustained social differences in survival [28]. Our findings also suggest that
socioeconomic position can modify the association between multimorbidity and mortality in men but
not in women.
We have not identified other studies of the outcome of socioeconomic position and joint
multimorbidity and frailty on mortality. One study [23] reported the combination of multimorbidity and
frailty to increase mortality risk, and adjustment by socioeconomic position resulted in no modification.
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In contrast, our stratified analysis on joint multimorbidity and frailty reveals occupational gradients in
association with mortality.
Bias toward healthy older adults [26,28] and healthy workers [27] is likely in several of the
studies, which will underestimate socioeconomic differences. Measuring multimorbidity as two
individual chronic conditions has lower age specificity and detects smaller socioeconomic gradients
than measures of organ-grouped conditions [9,20,38], which may impair the ability of such studies to
detect socioeconomic differences in mortality. In sum, differences in setting and measures may explain
variation in the impact of socioeconomic position and multimorbidity with mortality.
4.4. Strengths and Limitations
The HUNT Study is illustrative for Norway [33], and trends in the material match those of Western
high-income countries [39–41]. To avoid a bias toward healthy older adults and misclassification of
socioeconomic positions in younger age groups, we restricted the age range. Job opportunities and
exposures in work may differ among birth cohorts; therefore, we adjusted by age and used age as the
time scale in the analyses.
Occupation is an established comprehensive measure of socioeconomic position that may show
stronger associations with health outcomes than unidimensional measures [27]. Occupational group
classification enables international comparison [35].
There are no standard definitions or operationalizations of multimorbidity or frailty; however,
self-report is a valid approach to measure multimorbidity in larger samples [9]. HUNT3 covers a broad
range of conditions suitable to obtain proper estimates of multimorbidity [20]. We fitted HUNT3 data
to a multidimensional frailty measure in agreement with a holistic, conceptual definition of frailty [42].
Registry data ensured no loss to follow-up and the ability to link outcomes on an individual level.
Our cohort study offers a unique opportunity to directly compare the outcome of occupational
positioning and several multimorbidity measures on all-cause mortality. We compared mortality
with reference groups that may have some morbidities, as recommended by a recent review on
multimorbidity and mortality [19]. We reported absolute and relative mortality risk differences
stratified by sex and socioeconomic position to clarify characteristics that may be useful to inform
future interventions and are compliant with recommendations on reports of socioeconomic inequalities
in health [43].
The participants in this study may to some extent have higher socioeconomic position and
lower mortality compared with nonparticipants [44]. Further age restriction increased the proportion
of individuals categorized in high occupational groups compared with the occupational groups of
noneligible individuals. In sum, estimates of the association of multimorbidity and socioeconomic
position with mortality will be conservative. Events are relatively few, and imprecision limits the
interpretation of the results.
We only explored socioeconomic gradients by use of occupational positions. Various measures
of socioeconomic position act through distinct mechanisms and associate differently with health
outcomes [24,25]. Reverse causation, whereby prior health determines job opportunities, will increase
detected differences. Our measure excludes those who had never worked, and older women are more
likely to be missing because of unclassifiable occupations. This will probably underestimate social
gradients [45].
To assess prospective health outcomes, there are recommendations to use weighted multimorbidity
measures [46]. However, this was not possible with the data available. We lack information on chronicity
for most conditions and may overestimate prevalence of multimorbidity. The multimorbidity and frailty
measures are based on a count of conditions and dimensions and not types, which may vary among
occupational groups. The heterogeneity may bias estimates in either direction. As for recognized frailty
scales, our measure may differ in accuracy of detecting frailty across age groups [13,34]. This may
underestimate outcome measures.
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In this classic cohort study, we have measured multimorbidity at baseline. The duration of
exposure prior to HUNT3 will vary by occupational group. A lack of updated measurements of health
status may underestimate socioeconomic gradients [19].
4.5. Interpretation/Implication
Cautious of limitations and confounding, there was evidence of effect measure differences in
mortality between occupational groups by the number of chronic conditions in this population cohort
study, and these were stronger in men than women. Even complex measures of multimorbidity
were prevalent. All multimorbidity measures were strongly associated with mortality with varying
but consistent gradients between occupational groups and sex. It seems a continuous measure of
organ-grouped multimorbidity would better capture the impact of socioeconomic positioning on
mortality than categorical multimorbidity measures.
Norway is a high-income country with a well-developed welfare system. Primary and specialist
health care are mostly public and financed through taxation with low costs for the individual, as are all
levels of education. Job security and standards for health, safety, and environment in the workplace are
high. The results can be transferable to similar welfare state models but can also be contrasted across
different regime types. As others have noted, political systems and priorities shape population health
and the magnitude of health inequities [30]. Observed marked differences in multimorbidity and
mortality between occupational groups in our setting might suggest that labor protection legislation is
important in all societies.
The results support that social differences in multimorbidity must be a priority in public health
and should receive increased attention in health care. Improved management in the health care sector
necessitates reforms to fit the complexity of multimorbidity, from research and education to clinicians
and organization [34,47,48].
4.6. Future Research
The use of heterogenous multimorbidity measures in this study may obscure the relation to
mortality and any socioeconomic modification thereof [10]. It may be advantageous to study clusters of
multimorbidity to clarify causes and consequences [10]. Others have argued that clusters undermine that
the norm is multiplicity, which is more than the sum of its morbidities [49,50]. Complex multimorbidity
seems a relevant measure that captures this multiplicity while remaining sufficiently uniform to detect
social differences in mortality.
On this background, we recommend exploration of complex multimorbidity as well as clusters
of multimorbidity with repeated recordings and their association with a variety of socioeconomic
position measures, health care utilization, and mortality, in an attempt to enhance future prevention
and management of multimorbidity.
5. Conclusions
Multimorbidity is common and strongly associated with mortality with varying occupational
gradients. Men in lower occupational groups seems to be a particularly vulnerable group. Prevention of
multimorbidity is of public health importance in prolonging survival of all people. The health care
sector, from workforce to organization, needs to enhance the generalist and person-centered focus
sensitive to social context to better care for this large patient group. Continuous research on various
measures of multimorbidity and associations to multiple sociodemographic variables, health care use,
and mortality will be necessary to guide prevention and management.
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